Showing results (641-650 of 8,523) with videos related to

Sort By:
Pageof 853
Alimentary Pharmacology & Therapeutics|December 21, 2000
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication ratesF Canducci, A Armuzzi, F Cremonini, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2000
Phytomenadione or menadiol in the management of an elevated international normalized ratio (prothrombin time)B Green, S Cairns, R Harvey, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2017
Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort studyJ Busby, Ú McMenamin, A Spence, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2017
Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial managementJ McIlroy, G Ianiro, I Mukhopadhya, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2017
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infectionL-Y Mak, D K-H Wong, K-S Cheung, et al.
Alimentary Pharmacology & Therapeutics|November 22, 2017
Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's diseaseN Vande Casteele, B G Feagan, S Vermeire, et al.
Alimentary Pharmacology & Therapeutics|March 15, 2018
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strainsL Gatta, C Scarpignato, G Fiorini, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2018
Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infectionM Zamani, F Ebrahimtabar, V Zamani, et al.
Alimentary Pharmacology & Therapeutics|November 29, 2017
Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVESA A Butt, P Yan, O S Shaikh, et al.
Alimentary Pharmacology & Therapeutics|December 4, 2018
Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral loadMing Wang, Qian Bian, Yunxia Zhu, et al.
Pageof 853